Supernus Pharmaceuticals has acquired Sage Therapeutics, expanding its neuropsychiatric treatment offerings and positioning itself as a major player in the CNS therapeutic space.

Supernus Pharmaceuticals Inc is at a critical juncture, balancing high investor expectations with the need to prove its ability to innovate and execute effectively in the competitive pharmaceutical industry.